Literature DB >> 20190492

Diffuse alveolar hemorrhage following itraconazole injection.

Koichi Izumikawa1, Ken Nakano, Shintaro Kurihara, Yoshifumi Imamura, Kazuko Yamamoto, Taiga Miyazaki, Noriho Sakamoto, Masafumi Seki, Yuji Ishimatsu, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara, Tomoshi Tsuchiya, Naoya Yamasaki, Tsutomu Tagawa, Hiroshi Mukae, Takeshi Nagayasu, Shigeru Kohno.   

Abstract

Diffuse alveolar hemorrhage (DAH) syndrome is potentially fatal. We encountered a nearly fatal case of DAH possibly due to intravenous itraconazole (ITCZ). A 53-year-old man with chronic pulmonary aspergillosis underwent pneumonectomy of the left lung 15 days prior to the onset of DAH, which was confirmed by bronchoalveloar lavage. The battery of diagnostic evaluations performed revealed no other positive etiological factor, leading to the diagnosis of DAH possibly induced by intravenous ITCZ with a positive drug lymphocyte stimulation test. The patient did not respond to pulse methylprednisolone therapy, but responded dramatically to direct hemoperfusion using a polymyxin B-immobilized fiber column (PMX) therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190492     DOI: 10.2169/internalmedicine.49.2735

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  A case of life-threatening post-operative diffuse alveolar hemorrhage in patient with recent chemotherapy -A case report-.

Authors:  Mi-Young Kwon; Yoon Kyung Lee; In-Cheol Choi; Eun Ho Lee; Nam-Yun Kim; Young-Jae Chang
Journal:  Korean J Anesthesiol       Date:  2011-03-30

2.  A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.

Authors:  Xuejie Chen; Caihong Li; Da-Yun Jin; Brian Ingram; Zhenyu Hao; Xue Bai; Darrel W Stafford; Keping Hu; Jian-Ke Tie
Journal:  Blood       Date:  2020-08-13       Impact factor: 25.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.